This study aims to evaluate the effects of angiotensin receptor–neprilysin inhibitor (ARNI) on myocardial energy metabolism and prognosis in patients with acute myocardial infarction (AMI) complicated by heart failure (HF). The gene discussed is MME; the disease is heart failure.